Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...

Haleon PLC closed 6.63% below its 52-week high of £4.01, which the company reached on September 18th.

(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and ...

Haleon PLC closed 5.73% below its 52-week high of £4.01, which the company reached on September 18th.

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.

Haleon, an international manufacturer of medicine, vitamins and toothpaste, will upgrade its lab in Richmond's North Side at a cost of $54 million, the company announced Monday. Based in England ...

Pfizer (PFE) announces that it intends to sell approximately 700M ordinary shares in Haleon plc (HLN), representing approximately 7.7% of Haleon’s issued share capital. “There will be no sale ...

In a report released today, David Hayes from Jefferies maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

To calculate this metric for Haleon, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.09 = UK£2.5b ÷ (UK£33b - UK£5.6b ...

Pfizer has sold 700 million shares in British consumer-healthcare business Haleon for 2.50 billion pounds, equivalent to US$3.05 billion, it said in a statement. The U.S. drugmaker said Wednesday ...